Search Within

Geoffrey Yuyat Ku

Formats
  1. Meeting Abstract (108)
  2. Journal Article (105)
  3. Book Section (11)
  4. Review (8)
  5. Guidelines (2)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (239)
  2. Gastrointestinal Oncology Service (239)
  3. Hematologic Malignancies, Division of (239)
  4. Solid Tumor Oncology Division (239)
  5. Center for Pancreatic Cancer Research (102)
  6. Epidemiology and Biostatistics (96)

More Groups

People
  1. David Ilson (123)
  2. Yelena Janjigian (110)
  3. Marinela Capanu (55)
  4. David Kelsen (53)
  5. Steven Maron (51)
  6. Laura Tang (49)

More People

Years
  1. 2025 (16)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (19)
  5. 2021 (23)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (76)
  2. Annals of Oncology (22)
  3. Annals of Surgical Oncology (10)
  4. Clinical Cancer Research (10)
  5. International Journal of Radiation Oncology, Biology, Physics (7)
  6. Annals of Surgery (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Oxford University Press (26)
  3. Elsevier Inc. (23)
  4. Springer (21)
  5. American Association for Cancer Research (14)
  6. Lippincott Williams & Wilkins (10)

More Publishers

Results (239)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • T-cell inflamed gene expression profile (GEP) and PD-Li expression in patients (pts) with esophageal cancer (EC)
    Meeting Abstract

    Steiniche, T.; Rha, S. Y.; Chung, H. C.; Georgsen, J. B.; Ladekarl, M.; Nordsmark, M.; Jespersen, M. L.; Kim, H. S.; Kim, H.; Fein, C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic chemo (CTX) plus surgery and intraperitoneal (IP) CTX for patients (pts) with gastric cancer (GC) and peritoneal carcinomatosis (PC)
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second -line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)
    Meeting Abstract

    Greally, M.; Jha, S.; Yoon, S. S.; Li, J.; Desai, A. M.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Aljallad, K.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of durvalumab in combination with tremelimumab in patients with advanced gastric cancer with elevated tumor interferon-gamma gene signature
    Meeting Abstract

    Ku, G.; Lee, J.; Lenz, H. J.; Chee, C. E.; Omori, T.; Lee, K. W.; Chao, Y.; Catenacci, D.; Gibson, M.; Cohen, D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: Infeasible and illogical
    Editorial

    Greally, M.; Ku, G. Y.
    Journal of Thoracic Disease (2019)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer
    Journal Article

    Greally, M.; Chou, J. F.; Chatila, W. K.; Margolis, M.; Capanu, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Daian, F.; Ladanyi, M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Post-treatment ANC is predictive of poorer overall survival and disease-free survival in esophageal cancer patients after tri-modality therapy
    Meeting Abstract

    Zhang, M.; Jackson, A.; Montovano, M.; Ku, G.; Janjigian, Y.; Ilson, D. H.; Yorke, E. D.; Crane, C. H.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save
  • Genetic determinants of chemoradiation response and survival in locally advanced esophageal carcinoma treated with trimodality therapy
    Meeting Abstract

    Pitter, K. L.; Casey, D. L.; Oh, P.; Setton, J.; Ku, G.; Ilson, D. H.; Janjigian, Y.; Bains, M. S.; Jones, D.; Molena, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save